A Study of Pembrolizumab (MK-3475) Versus Paclitaxel for Participants With Advanced Gastric/Gastroesophageal Junction Adenocarcinoma That Progressed After Therapy With Platinum and Fluoropyrimidine (MK-3475-061/KEYNOTE-061)
Clinical trial NCT02370498 · COMPLETED
Trial details
- NCT number
- NCT02370498
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2015-05-11
- Primary completion
- 2017-10-26
- Enrollment
- 592
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.